A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection

Completed · Phase 3 · Has a placebo group

Conditions studied: Chronic Hepatitis B Virus, Pediatric

In brief

The purpose of this study was to evaluate the safety and efficacy of entecavir in pediatric patients with chronic hepatitis B virus infection

Key facts

Study ID
NCT01079806
Run by
Bristol-Myers Squibb
People needed
180
Starts
2010-06-30
Expected to finish
2018-03-31
Last updated by the study team
2019-05-09

Who can join

Age: 2 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.